Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Search by property

From Bioblast

This page provides a simple browsing interface for finding entities described by a property and a named value. Other available search interfaces include the page property search, and the ask query builder.

Search by property

A list of all pages that have property "Description" with value "[[File:1PGM;2D;3U;4S;5Rot-.png|300px]]". Since there have been only a few results, also nearby values are displayed.

Showing below up to 51 results starting with #1.

View (previous 100 | next 100) (20 | 50 | 100 | 250 | 500)


    

List of results

  • Absorbance spectrum  + (When light enters a sample, the amount of When light enters a sample, the amount of light that it absorbs is dependent upon the wavelength of the incident light. The '''absorbance spectrum''' is the curve derived by plotting the measured [[absorbance]] against the wavelength of the light emerging from the sample over a given [[wavelength range]]. An [[absorbance spectrum]] may be characterised by peaks and troughs (absorbance maxima and minima) that can be used to identify, and sometimes quantify, different absorbing substances present in a sample. absorbing substances present in a sample.)
  • O2k-MultiSensor  + (When one (or more) analytical parameters aWhen one (or more) analytical parameters are monitored simultaneously with oxygen concentration and oxygen flux, this is an '''O2k-MultiSensor''' application of the [[Oroboros O2k-technology]]. The [[NextGen-O2k]] supports all O2k-MultiSensor Modules, while the O2k does not provide for the Q- and NADH-Redox-Modules. For some O2k-MultiSensor applications it is necessary to introduce one or more additional sensors into the chamber through a MultiSensor stopper. Optical applications require the standard black stoppers.tions require the standard black stoppers.)
  • TIP2k syringe blocked  + (When the '''TIP2k syringe is blocked''', it must not be used with the TIP2k, and specific cleaning instructions should be followed.)
  • Living Communications  + (With '''Living Communications''', [https:/With '''Living Communications''', [https://www.bioenergetics-communications.org/index.php/bec Bioenergetics Communications] (BEC) takes the next step from pre-print to re-print. The concept of ''Living Communications'' pursues a novel culture of scientific communication, addressing the conflict between long-term elaboration and validation of results versus sharing without delay improved methods and preliminary findings. Following the preprint concept, updates may be posted on the BEC website of the resource publication. Updated versions of Living Communications are submitted for Open Peer Review with full traceability. In contrast to static papers, evolution of ''Living Communications'' is more resourceful and efficient than a ‘new’ publication. ''Living Communications'' provide a pathway along the scientific culture of lively debate towards tested and trusted milestones of research, from pre-print to re-print, from initial steps to next steps.e-print, from initial steps to next steps.)
  • Internal flow  + (Within the system boundaries, irreversibleWithin the system boundaries, irreversible '''internal flows''', ''I''<sub>i</sub>,—including chemical reactions and the dissipation of internal gradients of heat and matter—contribute to internal entropy production, d<sub>i</sub>''S''/d''t''. In contrast, [[external flow]]s, ''I''<sub>e</sub>, of heat, work, and matter proceed reversibly across the system boundaries (of zero thickness). Flows are expressed in various [[format]]s per unit of time, with corresponding [[motive unit]]s [MU], such as chemical [mol], electrical [C], mass [kg]. Flow is an [[extensive quantity]], in contrast to [[flux]] as a [[specific quantity]].ecific quantity]].)
  • Liver mitochondria purification  + ([[Armstrong 2010 J Comp Physiol B]]: This paper describes a method for purification of rodent liver mitochdondria using relatively low-speed centrifugation through discontinuous Percoll gradients.)
  • File:MitoFitPreprints and BEC manuscript template.docx  + ([[Bioenergetics Communications]] and [[MitoFit Preprints]] manuscript template.)
  • ET-pathway competent state  + ([[Electron transfer pathway]] competent state, ''see'' '''[[Electron-transfer-pathway state]]'''.)
  • Duroquinol  + ([[Electron-transfer-pathway state |ET-path[[Electron-transfer-pathway state |ET-pathway level 2]] is supported by '''duroquinol''' DQ feeding electrons into Complex III (CIII) with further electron transfer to CIV and oxygen. Upstream pathways are inhibited by rotenone and malonic acid in the absence of other substrates linked to ET-pathways with entry into the Q-junction.T-pathways with entry into the Q-junction.)
  • Fluorometric dyes  + ([[Extrinsic fluorophores]]; fluorescent markers.)
  • SUIT-014  + ([[File: 1GM;2D;3P;4S;5U;6Rot-.png|400px]])
  • O2k-sV-Module  + ([[File:11200-01.jpg|180px|right]] The '''[[File:11200-01.jpg|180px|right]] </br>The '''O2k-sV-Module''' is the O2k small-volume module, comprised of two Duran® glass chambers of 12 mm inner diameter specifically developed to perform high-resolution respirometry with reduced amounts of biological sample, and all the components necessary for a smaller operation volume ''V'' of 0.5 mL. The current DatLab version is included in the delivery of this revolutionary module.the delivery of this revolutionary module.)
  • SUIT-033  + ([[File:1D.1;2PGM;3D2.5-.png|450px]])
  • SUIT-038 O2 mt D091  + ([[File:1D;2M.1;2H2O;2c;3M.2;3M.5;3M1;3M2;4P;5G;6S10;6S50;7Gp;8U;9Rot;10Ama.png|400px]])
  • SUIT-041 O2 mt D096  + ([[File:1D;2M.1;3AC;3c;4M2;5P;6S;7Rot;8Ama.png|400px]])
  • SUIT-037 O2 mt D090  + ([[File:1D;2M.1;3Oct;3c;4M.2;4M.5;4M1;4M2;5P;6G;7S10;7S50;8Gp;9U;10Rot;11Ama.png|400px]])
  • SUIT-002 O2 mt D005  + ([[File:1D;2M.1;3Oct;3c;4M2;5P;6G;7S;8Gp;9U;10Rot;11Ama;12AsTm;13Azd.png|400px]])
  • SUIT-025  + ([[File:1D;2M.1;3Oct;3c;4M2;5P;6G;7S;8Rot-.png|600px]])
  • SUIT-025 O2 mt D057  + ([[File:1D;2M.1;3Oct;3c;4M2;5P;6G;7S;8Rot;9Ama.png|600px]])
  • SUIT-002  + ([[File:1D;2M.1;3Oct;4M2;5P;6G;7S;8Gp;9U;10Rot-.png|400px]])
  • SUIT-036 O2 mt D089  + ([[File:1D;2M.1;3Pal;3c;4M.2;4M.5;4M1;4M2;5P;6G;7S10;7S50;8Gp;9U;10Rot;11Ama.png|400px]])
  • SUIT-040 O2 mt D094  + ([[File:1D;2M.1;3Pal;3c;4M2;5P;6G;7S;8Gp;9U;10Rot;11Ama.png|400px]])
  • SUIT-040 O2 pfi D095  + ([[File:1D;2M.1;3Pal;3c;4M2;5P;6G;7S;8Gp;9U;10Rot;11Ama.png|400px]])
  • SUIT-039 O2 mt D092  + ([[File:1D;2M.1;3Pal;3c;4M2;5P;6G;7S;8U;9Rot;10Ama.png|400px]])
  • SUIT-039 O2 pfi D093  + ([[File:1D;2M.1;3Pal;3c;4M2;5P;6G;7S;8U;9Rot;10Ama.png|400px]])
  • SUIT-007  + ([[File:1G;2D;3M;4U-.png|300px]])
  • SUIT-014 O2 pfi D042  + ([[File:1GM;2D;2c;3P;4S;5U;6Rot;7Ama.png|400px]])
  • SUIT-021 O2 mt D035  + ([[File:1GM;2D;2c;3S;4Rot;5Omy;6U;7Ama.png|300px]])
  • SUIT-011 O2 pfi D024  + ([[File:1GM;2D;2c;3S;4U;5Rot;6Ama.png|400px]])
  • SUIT-021  + ([[File:1GM;2D;3S;4Rot;5Omy;6U-.png|400px]])
  • SUIT-021 Fluo mt D036  + ([[File:1GM;2D;3S;4Rot;5Omy;6U;7Ama.png|300px]])
  • SUIT-011  + ([[File:1GM;2D;3S;4U;5Rot-.png|400px|SUIT-011]])
  • SUIT-018  + ([[File:1GMS;2D-.png|300px|SUIT-018]])
  • SUIT-018 O2 mt D054  + ([[File:1GMS;2D;2c;3Ama.png|290px]])
  • SUIT-018 AmR mt D031  + ([[File:1GMS;2D;3Ama.png|290px]])
  • SUIT-018 AmR mt D041  + ([[File:1GMS;2D;3Ama.png|290px]])
  • SUIT-018 AmR mt D040  + ([[File:1GMS;2D;3Ama.png|290px|SUIT-018]])
  • SUIT-027  + ([[File:1M;2D;3M;4P;5G-.png|400px]])
  • SUIT-017  + ([[File:1OctM;2D;2c;3G;4S;5U;6Rot-.png |355px]])
  • SUIT-017 O2 pfi D049  + ([[File:1OctM;2D;2c;3G;4S;5U;6Rot;7Ama.png|350px]])
  • SUIT-005 O2 pfi D011  + ([[File:1OctM;2D;2c;3P;4S;5U;6Rot;7Ama;8AsTm;9Azd.png|450px]])
  • SUIT-017 O2 mt D046  + ([[File:1OctM;2D;3G;3c;4S;5U;6Rot;7Ama.png |350px]])
  • SUIT-015  + ([[File:1OctM;2D;3G;4P;5S;6U;7Rot-.png|451px]])
  • SUIT-015 O2 pti D043  + ([[File:1OctM;2D;3G;4P;5S;6U;7Rot;8Ama.png|450px]])
  • SUIT-016  + ([[File:1OctM;2D;3G;4S;5Rot;6Omy;7U-.png|420px]])
  • SUIT-016 O2 pfi D044  + ([[File:1OctM;2D;3G;4S;5Rot;6Omy;7U;7c-8Ama.jpg|400px]])
  • SUIT-005  + ([[File:1OctM;2D;3P;4S;5U;6Rot-.png|300px]])
  • 1OctM;2D;3PG;4S;5U;6Rot-  + ([[File:1OctM;2D;3PG;4S;5U;6Rot-.png|300px]])
  • 1PGM;2D;3S;4Rot;5U-  + ([[File:1PGM;2D;3S;4Rot;5U-.png|300px]])
  • SUIT-028  + ([[File:1PGM;2D;3S;4U;5Rot-.png|400px|SUIT-028]])
  • SUIT-020 O2 mt D032  + ([[File:1PM;2D;2c;3G;4S;5Rot;6Omy;7U;8Ama.png|500px]])
  • SUIT-008 O2 pfi D014  + ([[File:1PM;2D;2c;3G;4S;5U;6Rot;7Ama;8AsTm;9Azd.png|400px]])
  • SUIT-008 O2 mt D026  + ([[File:1PM;2D;2c;3G;4S;5U;6Rot;7Ama;8AsTm;9Azd.png|600px]])
  • SUIT-012 O2 mt D027  + ([[File:1PM;2D;2c;3G;4U;5Ama.png|300px]])
  • SUIT-006 O2 mt D047  + ([[File:1PM;2D;2c;3Omy;4U;5Ama.png|300px]])
  • SUIT-031 O2 mt D075  + ([[File:1PM;2D;2c;3S;4Rot;5U;6Ama.png|400px]])
  • SUIT-001  + ([[File:1PM;2D;2c;3U;4G;5S;6Oct;7Rot;8Gp-.png|400px|SUIT-001]])
  • SUIT-004 O2 pfi D010  + ([[File:1PM;2D;2c;3U;4S;5Rot;6Ama;7AsTm;8Azd.png|450px]])
  • SUIT-006 MgG mt D055  + ([[File:1PM;2D;3Cat;4U;5Ama.png|300px]])
  • SUIT-020  + ([[File:1PM;2D;3G;4S;5Rot;6Omy;7U-.png|400px]])
  • SUIT-020 Fluo mt D033  + ([[File:1PM;2D;3G;4S;5Rot;6Omy;7U;8Ama.png|450px]])
  • SUIT-008 O2 pce D25  + ([[File:1PM;2D;3G;4S;5U;6Rot-.png|300px]])
  • SUIT-008  + ([[File:1PM;2D;3G;4S;5U;6Rot.png|400px]])
  • SUIT-012  + ([[File:1PM;2D;3G;4U-.png|300px]])
  • 1PM;2D;3G;4U;5S;6Rot-  + ([[File:1PM;2D;3G;4U;5S;6Rot-.png|300px]])
  • SUIT-006 Fluo mt D034  + ([[File:1PM;2D;3Omy;4U;5Ama.png|300px]])
  • SUIT-006 AmR mt D048  + ([[File:1PM;2D;3Omy;4U;5Ama.png|400px]])
  • SUIT-031  + ([[File:1PM;2D;3S;4Rot;5U;-.png|400px]])
  • SUIT-004  + ([[File:1PM;2D;3U;4S;5Rot.png|450px]])
  • SUIT-029 O2 mt D066  + ([[File:1PM;2T;2D;2c;3Omy;4U;5G;6S;6U;7Rot;8Ama.png|350px]])
  • SUIT-019 O2 pfi D045  + ([[File:1PalM;2D;2c;3Oct;4P;5G;6U;7S;8Rot;9Ama.png|400px]])
  • SUIT-019  + ([[File:1PalM;2D;3Oct;4P;5G;6U;7S;8Rot-.png|450px]])
  • SUIT-009 O2 mt D015  + ([[File:1S;2D;2c;3P;4Rot;5Ama.png|400px|SUIT9]])
  • SUIT-009  + ([[File:1S;2D;3P;4Rot-.png|400px|SUIT9]])
  • SUIT-009 AmR mt D021  + ([[File:1S;2D;3P;4Rot;5Ama.png|400px|SUIT-009]])
  • SUIT-026 O2 mt D063  + ([[File:1S;2Rot;3D;3c;4Ama.png|400px]])
  • SUIT-026  + ([[File:1S;2Rot;3D;4Ama.png|350px]])
  • SUIT-006 O2 mt D022  + ([[File:1SRot;2D;2c;3(Omy);4U;5Ama.png|400px]])
  • SUIT-006  + ([[File:1X;2D;2c;3Omy;4U-.png|450px]])
  • SUIT-003 O2 ce D009  + ([[File:1ce;2ceOmy;3ceU-.jpg|450px]])
  • SUIT-003 Ce1;ce2U-  + ([[File:1ce;2ceU-.jpg|150px]])
  • SUIT-003 Ce1;ce3U-  + ([[File:1ce;3ceU-.jpg|150px]])
  • SUIT-032 NADH mt D078  + ([[File:1mt;1PGM;2D;3Anox;4Myx;5Reox.png|300px]])
  • Oxoglutarate  + ([[File:2-Oxoglutaric_acid.jpg|left|100px|2[[File:2-Oxoglutaric_acid.jpg|left|100px|2-Oxoglutaric acid]]</br>'''2-Oxoglutaric acid''' or alpha-ketoglutaric acid, C<sub>5</sub>H<sub>6</sub>O<sub>5</sub>, occurs under physiological conditions as the anion '''2-Oxoglutarate<sup>2-</sup>, Og'''. 2-Oxoglutarate (alpha-ketoglutarate) is formed from isocitrate as a product of [[isocitrate dehydrogenase]] (IDH) in the [[TCA cycle]], and is a substrate of [[oxoglutarate dehydrogenase]] (OgDH). The 2-oxoglutarate carrier exchanges malate<sup>2-</sup> for 2-oxoglutarate<sup>2-</sup> as part of the [[malate-aspartate shuttle]]. In the cytosol, oxoglutarate+aspartate are transaminated to form oxaloacetate+glutamate. Cytosolic malate dehydrogenase converts oxaloacetate+NADH to malate.transaminated to form oxaloacetate+glutamate. Cytosolic malate dehydrogenase converts oxaloacetate+NADH to malate.)
  • Mitochondria-Targeted Drug Development  + ([[File:21640 - Mitochondria Targeted Thera[[File:21640 - Mitochondria Targeted Therapeutics logo NEW.jpg|200px|left|Mitochondria-Targeted Drug Development]]</br>The '''Mitochondria-Targeted Drug Development Summit''' was first established in 2021, as an online conference. Due to its success and unmatched focus, the 2<sup>nd</sup> edition returns to Boston this March 2022. </br>This is the only industry-led meeting that unites key stakeholders under a mutual and ambitious objective of '''accelerating the discovery and development of novel drugs that target mitochondrial functions''' for chronic, primary mitochondrial diseases, muscular dystrophy, metabolic disorders, and neurodegenerative diseases.</br>Join our speakers from '''GenSight Biologics, Abliva, Reneo Pharma, Mito BioPharma, Mitokinin''' and more with exciting networking opportunities, panel discussions and dedicated roundtables.tunities, panel discussions and dedicated roundtables.)
  • Screwdriver allen wrench  + ([[File:24330-02.jpg|right|180px]]'''Screwdriver allen wrench''', a standard component of the [[O2k-FluoRespirometer]] and [[O2k-sV-Module]].)
  • MultiSensor-Connector  + ([[File:30420-24 MultiSensorConnector.JPG|right|180px]] '''MultiSensor-Connector''': for separate reference electrode and [[ISE]]; only for O2k-Series B and Series C with MultiSensor electronic upgrading before 2011.)
  • MultiSensor-Preamplifier 1/100  + ([[File:30430--24 NO-Attachment.JPG|right|180px]] '''MultiSensor-Preamplifier 1/100''': Required only for O2k-Series A-C, for application of NO (or other amperometric) sensors (single chamber mode of application).)
  • TIP2k-Needle Safety Support with cable guide  + ([[File:31330-01 3.jpg|right|280px]] '''TIP2k-Needle Safety Support with cable guide''': for safe storage of TIP2k-needles and MultiSensor Modules cables when not required during the experiment.)
  • Storage box sV  + ([[File:32001-01.jpg|right|180px]]'''Storage box sV''' empty, for storage of [[O2k-sV-Module]] components.)
  • O2k-Chamber Holder sV  + ([[File:32100-01.jpg|right|180px]]'''O2k-Chamber Holder sV''' (black POM) for PVDF or PEEK stoppers (0.5-mL [[O2k-chamber]]), with [[O-ring\Viton\16x2 mm]] and [[V-ring\30-35-4.5 mm]].)
  • POS-Holder sV  + ([[File:32300-01.jpg|right|180px]] '''POS-H[[File:32300-01.jpg|right|180px]]</br>'''POS-Holder sV''', made from black POM, to be screwed into the copper block of the [[O2k-Main Unit]], guiding the [[OroboPOS|POS]] to the [[O2k-Chamber sV]], and keeping the SmartPOS/OroboPOS-Connector in a fixed position for sealing the O2k-Chamber sV with the [[POS-Seal Tip]]. In addition, the POS-Holder sV fixes the O2k-Chamber sV in an accurate rotational position by pressing against the angular cut of the glass chamber.inst the angular cut of the glass chamber.)
  • O2k-Chamber sV  + ([[File:33100-01.jpg|right|180px]]'''O2k-Chamber sV''': 12 mm inner diameter, Duran® glass polished, with standard operation volume ''V'' of 0.5 mL.)
  • Stirrer-Bar sV\white PVDF\11.5x6.2 mm  + ([[File:33210-01.jpg|right|180px]]'''Stirre[[File:33210-01.jpg|right|180px]]'''Stirrer-Bar sV\white [[PVDF]]\11.5x6.2 mm''', operated in the 0.5-mL [[O2k-Chamber sV]] at constant stirring speed (standard is 750 rpm, or 12.5 Hz), to provide optimum mixing of the sample in the aqueous medium and ensure a stable signal of the polarographic oxygen sensor ([[OroboPOS]]) placed in a position of maximum current of the medium.position of maximum current of the medium.)
  • Stopper sV\black PEEK\conical Shaft\central Port  + ([[File:34000-01.jpg|right|180px]]'''Stoppe[[File:34000-01.jpg|right|180px]]'''Stopper sV\black PEEK\conical Shaft\central Port''': with conical shaft (with PTFE, graphite, carbon fiber) and one central capillary (1.0 mm diameter; 48.9 mm length), [[Volume-Calibration Ring sV]] (A or B) for volume adjustment 0.5 mL; 2 mounted O-rings ([[O-ring sV\Viton\9.5x1 mm]]).[[O-ring sV\Viton\9.5x1 mm]]).)
  • O-ring sV\Viton\9.5x1 mm  + ([[File:34310-02.jpg|right|180px]]'''O-ring sV\[[Viton]]\9.5x1 mm''', for [[Stopper sV\black PEEK\conical Shaft\central Port | PEEK Stopper sV]], 2 are mounted on each PEEK Stopper sV, box of 8 as spares.)
  • Asia Society for Mitochondrial Research and Medicine  + ([[File:ASMRM LOGO.JPG|200px|left]]The '''Asia Society for Mitochondrial Research and Medicine''' (ASMRM) was founded in 2003 to share the latest knowledge on mitochondrial research.)
  • Acetyl-CoA  + ([[File:Acetyl coenzyme A 700.png|left|200p[[File:Acetyl coenzyme A 700.png|left|200px|acetyl-CoA]]'''Acetyl-CoA''', C<sub>23</sub>H<sub>38</sub>N<sub>7</sub>O<sub>17</sub>P<sub>3</sub>S, is a central piece in metabolism involved in several biological processes, but its main role is to deliver the acetyl group into the [[TCA cycle]] for its oxidation. It can be synthesized in different pathways: (i) in glycolysis from [[pyruvate]], by pyruvate dehydrogenase, which also forms NADH; (ii) from fatty acids β-oxidation, which releases one acetyl-CoA each round; (iii) in the catabolism of some amino acids such as leucine, lysine, phenylalanine, tyrosine and tryptophan.</br><br>In the mitochondrial matrix, acetyl-CoA is condensed with [[oxaloacetate]] to form [[citrate]] through the action of [[citrate synthase]] in the [[tricarboxylic acid cycle]]. Acetyl-CoA cannot cross the mitochondrial inner membrane but citrate can be transported out of the mitochondria. In the cytosol, citrate can be converted to acetyl-CoA and be used in the synthesis of fatty acid, cholesterol, ketone bodies, acetylcholine, and other processes. and be used in the synthesis of fatty acid, cholesterol, ketone bodies, acetylcholine, and other processes.)
  • Aconitase  + ([[File:Aconitase.jpg|right|500px|aconitase[[File:Aconitase.jpg|right|500px|aconitase]]'''Aconitase''' is a [[TCA cycle]] enzyme that catalyzes the reversible isomerization of [[citrate]] to [[isocitrate]]. Also, an isoform is also present in the cytosol acting as a trans-regulatory factor that controls iron homeostasis at a post-transcriptional level.<br>tasis at a post-transcriptional level.<br>)
  • Cardiovascular Exercise Research Group  + ([[File:CERG.gif|200px|left|CERG]] The '''C[[File:CERG.gif|200px|left|CERG]]</br>The '''Cardiovascular Exercise Research Group''' (CERG) was established in January 2008 and their research focuses on identifying the key cellular and molecular mechanisms underlying the beneficial effects of physical exercise on the heart, arteries and skeletal muscle in the context of disease prevention and management through experimental, clinical and epidemiological studies. </br>Since 2003 this research group organizes the biennial seminar [http://www.ntnu.edu/cerg/seminar-2013 "Exercise in Medicine"] in Trondheim, Norway.ercise in Medicine"] in Trondheim, Norway.)